Trials / Completed
CompletedNCT03101189
A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects
A Single-center, Double-blind, Placebo-controlled, Randomized Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-dose ACT-541468 in Healthy Japanese and Caucasian Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Idorsia Pharmaceuticals Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
So far, ACT-541468 has been studied mainly in Caucasian subjects. The present study will bridge results obtained in Caucasian subjects to those in Japanese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACT-541468 | Capsule |
| DRUG | placebo | Matching placebo capsule |
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2017-04-24
- Completion
- 2017-04-26
- First posted
- 2017-04-05
- Last updated
- 2018-07-10
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03101189. Inclusion in this directory is not an endorsement.